Published in Nature on September 09, 1993
Botulinum Toxin to Treat Restless Legs Syndrome | NCT00479154
Membrane fusion: grappling with SNARE and SM proteins. Science (2009) 8.98
Vam7p, a SNAP-25-like molecule, and Vam3p, a syntaxin homolog, function together in yeast vacuolar protein trafficking. Mol Cell Biol (1998) 2.80
The t-SNAREs syntaxin 1 and SNAP-25 are present on organelles that participate in synaptic vesicle recycling. J Cell Biol (1995) 2.72
Tetanus toxin-mediated cleavage of cellubrevin impairs exocytosis of transferrin receptor-containing vesicles in CHO cells. J Cell Biol (1994) 2.46
A novel tetanus neurotoxin-insensitive vesicle-associated membrane protein in SNARE complexes of the apical plasma membrane of epithelial cells. Mol Biol Cell (1998) 2.11
A rat brain Sec1 homologue related to Rop and UNC18 interacts with syntaxin. Proc Natl Acad Sci U S A (1994) 2.07
rbSec1A and B colocalize with syntaxin 1 and SNAP-25 throughout the axon, but are not in a stable complex with syntaxin. J Cell Biol (1995) 2.02
Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A (1999) 1.99
Synaptic vesicle exocytosis. Cold Spring Harb Perspect Biol (2011) 1.97
Single vesicle millisecond fusion kinetics reveals number of SNARE complexes optimal for fast SNARE-mediated membrane fusion. J Biol Chem (2009) 1.89
Vam7p, a vacuolar SNAP-25 homolog, is required for SNARE complex integrity and vacuole docking and fusion. EMBO J (1998) 1.89
Syntaxin 4, VAMP2, and/or VAMP3/cellubrevin are functional target membrane and vesicle SNAP receptors for insulin-stimulated GLUT4 translocation in adipocytes. Mol Cell Biol (1997) 1.85
Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J Cell Biol (2003) 1.81
ROP, the Drosophila Sec1 homolog, interacts with syntaxin and regulates neurotransmitter release in a dosage-dependent manner. EMBO J (1998) 1.70
Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons. Mol Biol Cell (2008) 1.66
SNARE-catalyzed fusion events are regulated by Syntaxin1A-lipid interactions. Mol Biol Cell (2007) 1.62
Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes. Proc Natl Acad Sci U S A (2007) 1.59
VAMP-2 and cellubrevin are expressed in pancreatic beta-cells and are essential for Ca(2+)-but not for GTP gamma S-induced insulin secretion. EMBO J (1995) 1.56
SNAP-25 is expressed in islets of Langerhans and is involved in insulin release. J Cell Biol (1995) 1.48
Endobrevin, a novel synaptobrevin/VAMP-like protein preferentially associated with the early endosome. Mol Biol Cell (1998) 1.43
A neuronal cell-based botulinum neurotoxin assay for highly sensitive and specific detection of neutralizing serum antibodies. FEBS Lett (2007) 1.40
Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses. Philos Trans R Soc Lond B Biol Sci (1999) 1.39
Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities. J Clin Microbiol (1996) 1.39
Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised double blind placebo controlled trial. J Neurol Neurosurg Psychiatry (2000) 1.37
Identification of synaptic proteins and their isoform mRNAs in compartments of pancreatic endocrine cells. Proc Natl Acad Sci U S A (1994) 1.35
LTP requires a unique postsynaptic SNARE fusion machinery. Neuron (2013) 1.33
Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc Natl Acad Sci U S A (2004) 1.29
Cellubrevin and synaptobrevins: similar subcellular localization and biochemical properties in PC12 cells. J Cell Biol (1995) 1.28
Mechanisms and function of dendritic exocytosis. Neuron (2011) 1.28
Differential expression of SNAP-25 protein isoforms during divergent vesicle fusion events of neural development. Proc Natl Acad Sci U S A (1995) 1.27
Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism. J Biol Chem (2011) 1.27
Exocytotic mechanism studied by truncated and zero layer mutants of the C-terminus of SNAP-25. EMBO J (2000) 1.26
Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay. Appl Environ Microbiol (1999) 1.25
Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors. PLoS Pathog (2011) 1.24
High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A. Infect Immun (2001) 1.22
Metabolic discrimination of select list agents by monitoring cellular responses in a multianalyte microphysiometer. Sensors (Basel) (2009) 1.19
A role for soluble NSF attachment proteins (SNAPs) in regulated exocytosis in adrenal chromaffin cells. EMBO J (1995) 1.18
Expression of vesicle-associated membrane protein 2 (VAMP-2)/synaptobrevin II and cellubrevin in rat skeletal muscle and in a muscle cell line. Biochem J (1994) 1.16
Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species. Infect Immun (1998) 1.16
SV2 mediates entry of tetanus neurotoxin into central neurons. PLoS Pathog (2010) 1.15
Antibody mapping to domains of botulinum neurotoxin serotype A in the complexed and uncomplexed forms. Infect Immun (1997) 1.15
Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons. J Cell Biol (2007) 1.15
SNAP-25 and synaptotagmin involvement in the final Ca(2+)-dependent triggering of neurotransmitter exocytosis. Proc Natl Acad Sci U S A (1996) 1.15
Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett (2011) 1.13
Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain. PLoS One (2008) 1.11
A phosphatidylinositol 4,5-bisphosphate-sensitive casein kinase I alpha associates with synaptic vesicles and phosphorylates a subset of vesicle proteins. J Cell Biol (1995) 1.11
Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child (2000) 1.10
Myofiber length and three-dimensional localization of NMJs in normal and botulinum toxin treated adult extraocular muscles. Invest Ophthalmol Vis Sci (2007) 1.10
Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro. Infect Immun (2013) 1.10
Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Res (2011) 1.09
Domains of alpha-SNAP required for the stimulation of exocytosis and for N-ethylmalemide-sensitive fusion protein (NSF) binding and activation. Mol Biol Cell (1996) 1.08
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1. FEBS Lett (2010) 1.07
Evidence for a voltage-dependent enhancement of neurotransmitter release mediated via the synaptic protein interaction site of N-type Ca2+ channels. Proc Natl Acad Sci U S A (1998) 1.05
The cysteine-string domain of the secretory vesicle cysteine-string protein is required for membrane targeting. Biochem J (1998) 1.04
A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate. Structure (2008) 1.03
Detection of botulinum neurotoxin serotype B at sub mouse LD(50) levels by a sandwich immunoassay and its application to toxin detection in milk. PLoS One (2010) 1.03
Neurologic uses of botulinum neurotoxin type A. Neuropsychiatr Dis Treat (2007) 1.02
The SNARE complex from yeast is partially unstructured on the membrane. Structure (2008) 1.01
Synaptobrevin/vesicle-associated membrane protein (VAMP) of Aplysia californica: structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F. Proc Natl Acad Sci U S A (1994) 1.01
Regulated vesicular fusion in neurons: snapping together the details. Proc Natl Acad Sci U S A (1994) 1.00
Assembly and function of the botulinum neurotoxin progenitor complex. Curr Top Microbiol Immunol (2013) 1.00
Functional characterization of botulinum neurotoxin serotype H as a hybrid of known serotypes F and A (BoNT F/A). Anal Chem (2015) 1.00
Cytotoxicity of botulinum neurotoxins reveals a direct role of syntaxin 1 and SNAP-25 in neuron survival. Nat Commun (2013) 0.99
Cell biology. Snappy exocytoxins. Nature (1993) 0.99
Chirality holds the key for potent inhibition of the botulinum neurotoxin serotype a protease. Org Lett (2010) 0.99
A fluorescence detection platform using spatial electroluminescent excitation for measuring botulinum neurotoxin A activity. Biosens Bioelectron (2008) 0.99
Botulinum neurotoxin serotype A specific cell-based potency assay to replace the mouse bioassay. PLoS One (2012) 0.98
Benzoquinones as inhibitors of botulinum neurotoxin serotype A. Bioorg Med Chem (2014) 0.98
SNARE tagging allows stepwise assembly of a multimodular medicinal toxin. Proc Natl Acad Sci U S A (2010) 0.98
P2X7 receptors trigger ATP exocytosis and modify secretory vesicle dynamics in neuroblastoma cells. J Biol Chem (2011) 0.98
Stimulation-induced changes in NADH fluorescence and mitochondrial membrane potential in lizard motor nerve terminals. J Physiol (2007) 0.98
A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam. J Neurophysiol (2011) 0.98
Sensing the deadliest toxin: technologies for botulinum neurotoxin detection. Toxins (Basel) (2010) 0.97
A single amino acid near the C terminus of the synaptosomeassociated protein of 25 kDa (SNAP-25) is essential for exocytosis in chromaffin cells. Proc Natl Acad Sci U S A (1999) 0.97
Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system. Infect Immun (2012) 0.97
Progress in cell based assays for botulinum neurotoxin detection. Curr Top Microbiol Immunol (2013) 0.96
SNAP-25a and -25b isoforms are both expressed in insulin-secreting cells and can function in insulin secretion. Biochem J (1999) 0.96
Differential gene expression and functional analysis implicate novel mechanisms in enteric nervous system precursor migration and neuritogenesis. Dev Biol (2006) 0.96
Expression of genes encoding multi-transmembrane proteins in specific primate taste cell populations. PLoS One (2009) 0.96
Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT/A2, /F4, and /F5. Anal Chem (2014) 0.95
Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering. Toxins (Basel) (2010) 0.95
Ectopic vesicular neurotransmitter release along sensory axons mediates neurovascular coupling via glial calcium signaling. Proc Natl Acad Sci U S A (2010) 0.95
Functional studies in 3T3L1 cells support a role for SNARE proteins in insulin stimulation of GLUT4 translocation. Biochem J (1997) 0.95
Botulinum neurotoxin C initiates two different programs for neurite degeneration and neuronal apoptosis. J Cell Biol (2005) 0.95
Rab proteins in gastric parietal cells: evidence for the membrane recycling hypothesis. Yale J Biol Med (1997) 0.94
Differential palmitoylation regulates intracellular patterning of SNAP25. J Cell Sci (2011) 0.93
In vitro detection and quantification of botulinum neurotoxin type e activity in avian blood. Appl Environ Microbiol (2011) 0.92
miR-153 regulates SNAP-25, synaptic transmission, and neuronal development. PLoS One (2013) 0.92
Intravesical treatments of bladder pain syndrome/interstitial cystitis. Nat Rev Urol (2012) 0.92
Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment. Headache (2012) 0.92
A second SNARE role for exocytic SNAP25 in endosome fusion. Mol Biol Cell (2006) 0.92
Resolving single membrane fusion events on planar pore-spanning membranes. Sci Rep (2015) 0.91
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A). PLoS Pathog (2013) 0.91
Sensitive and quantitative detection of botulinum neurotoxin in neurons derived from mouse embryonic stem cells. Biochem Biophys Res Commun (2010) 0.90
Unique ganglioside recognition strategies for clostridial neurotoxins. J Biol Chem (2011) 0.90
Multi-wavelength Spatial LED illumination based detector for in vitro detection of Botulinum Neurotoxin A Activity. Sens Actuators B Chem (2010) 0.90
Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination. PLoS One (2011) 0.90
Lab-on-a-chip for botulinum neurotoxin a (BoNT-A) activity analysis. Lab Chip (2009) 0.89
Membrane fusion as a team effort. Proc Natl Acad Sci U S A (2007) 0.89
CAPS and Munc13: CATCHRs that SNARE Vesicles. Front Endocrinol (Lausanne) (2013) 0.89
Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature (1998) 15.80
SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med (2008) 11.31
Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals. Nature (1995) 7.81
Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation. J Cell Biol (1983) 7.55
Synaptotagmin I: a major Ca2+ sensor for transmitter release at a central synapse. Cell (1994) 7.43
Membrane fusion and exocytosis. Annu Rev Biochem (1999) 7.35
A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science (2001) 7.03
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature (1990) 6.71
Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell (1995) 5.97
Synaptotagmin I functions as a calcium regulator of release probability. Nature (2001) 5.96
Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science (2000) 5.89
Structure and conformational changes in NSF and its membrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy. Cell (1997) 5.72
Functional partnership between amphiphysin and dynamin in clathrin-mediated endocytosis. Nat Cell Biol (1999) 5.56
The LDL receptor gene: a mosaic of exons shared with different proteins. Science (1985) 5.49
Targeted expression of tetanus toxin light chain in Drosophila specifically eliminates synaptic transmission and causes behavioral defects. Neuron (1995) 5.42
Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc Natl Acad Sci U S A (1999) 5.39
Generation of high curvature membranes mediated by direct endophilin bilayer interactions. J Cell Biol (2001) 5.37
A conformational switch in syntaxin during exocytosis: role of munc18. EMBO J (1999) 5.07
Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly. EMBO J (1994) 5.02
C2-domains, structure and function of a universal Ca2+-binding domain. J Biol Chem (1998) 5.01
Synaptotagmin: a calcium sensor on the synaptic vesicle surface. Science (1992) 5.00
Conserved structural features of the synaptic fusion complex: SNARE proteins reclassified as Q- and R-SNAREs. Proc Natl Acad Sci U S A (1998) 4.99
Synaptic vesicle fusion complex contains unc-18 homologue bound to syntaxin. Nature (1993) 4.93
Accessory factors in clathrin-dependent synaptic vesicle endocytosis. Nat Rev Neurosci (2000) 4.72
Vesicle fusion from yeast to man. Nature (1994) 4.71
Essential role of phosphoinositide metabolism in synaptic vesicle recycling. Cell (1999) 4.70
Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C. Nature (1990) 4.68
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet (2000) 4.60
Mutation in LDL receptor: Alu-Alu recombination deletes exons encoding transmembrane and cytoplasmic domains. Science (1985) 4.51
Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science (1992) 4.47
A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci U S A (1985) 4.35
SNAREs are concentrated in cholesterol-dependent clusters that define docking and fusion sites for exocytosis. EMBO J (2001) 4.32
Structures, alternative splicing, and neurexin binding of multiple neuroligins. J Biol Chem (1996) 4.31
Essential functions of synapsins I and II in synaptic vesicle regulation. Nature (1995) 4.25
Epsin is an EH-domain-binding protein implicated in clathrin-mediated endocytosis. Nature (1998) 4.24
SNARE function analyzed in synaptobrevin/VAMP knockout mice. Science (2001) 4.09
Cellubrevin is a ubiquitous tetanus-toxin substrate homologous to a putative synaptic vesicle fusion protein. Nature (1993) 4.09
Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature (2000) 3.98
Structure of the first C2 domain of synaptotagmin I: a novel Ca2+/phospholipid-binding fold. Cell (1995) 3.94
Binding of neuroligins to PSD-95. Science (1997) 3.88
Ca(2+)-dependent and -independent activities of neural and non-neural synaptotagmins. Nature (1995) 3.85
Protein p38: an integral membrane protein specific for small vesicles of neurons and neuroendocrine cells. J Cell Biol (1986) 3.68
Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature (1999) 3.65
Endophilin/SH3p4 is required for the transition from early to late stages in clathrin-mediated synaptic vesicle endocytosis. Neuron (1999) 3.64
Rim is a putative Rab3 effector in regulating synaptic-vesicle fusion. Nature (1997) 3.63
Generation of coated intermediates of clathrin-mediated endocytosis on protein-free liposomes. Cell (1998) 3.62
Multipartite entanglement among single spins in diamond. Science (2008) 3.60
Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions. Science (1997) 3.59
A presynaptic inositol-5-phosphatase. Nature (1996) 3.54
The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation. Genes Dev (1991) 3.52
Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss of the hippocampus. Neuron (2001) 3.51
Synapsin I (Protein I), a nerve terminal-specific phosphoprotein. II. Its specific association with synaptic vesicles demonstrated by immunocytochemistry in agarose-embedded synaptosomes. J Cell Biol (1983) 3.49
Complexins regulate a late step in Ca2+-dependent neurotransmitter release. Cell (2001) 3.49
Synaptobrevin: an integral membrane protein of 18,000 daltons present in small synaptic vesicles of rat brain. EMBO J (1989) 3.44
Three-dimensional structure of an evolutionarily conserved N-terminal domain of syntaxin 1A. Cell (1998) 3.40
Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity. Nat Neurosci (1998) 3.37
A quantitative dot-immunobinding assay for proteins using nitrocellulose membrane filters. Proc Natl Acad Sci U S A (1984) 3.35
A single C2 domain from synaptotagmin I is sufficient for high affinity Ca2+/phospholipid binding. J Biol Chem (1993) 3.34
RIBEYE, a component of synaptic ribbons: a protein's journey through evolution provides insight into synaptic ribbon function. Neuron (2000) 3.21
Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med (1990) 3.21
Putative receptor for inositol 1,4,5-trisphosphate similar to ryanodine receptor. Nature (1989) 3.17
Dynamin and its partners: a progress report. Curr Opin Cell Biol (1998) 3.15
Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus. Nature (1984) 3.15
rab3 is a small GTP-binding protein exclusively localized to synaptic vesicles. Proc Natl Acad Sci U S A (1990) 3.13
Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. J Biol Chem (1990) 3.13
A functional link between dynamin and the actin cytoskeleton at podosomes. J Cell Biol (2000) 3.12
The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology 3 domain. Proc Natl Acad Sci U S A (1997) 3.11
Three-dimensional structure of the synaptotagmin 1 C2B-domain: synaptotagmin 1 as a phospholipid binding machine. Neuron (2001) 3.10
Cartography of neurexins: more than 1000 isoforms generated by alternative splicing and expressed in distinct subsets of neurons. Neuron (1995) 3.09
Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin. EMBO J (1993) 3.08
A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain. Cell (1998) 3.05
Complexins: cytosolic proteins that regulate SNAP receptor function. Cell (1995) 3.04
The synaptic vesicle cycle: a single vesicle budding step involving clathrin and dynamin. J Cell Biol (1996) 3.03
A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol (2001) 2.98
Development and evaluation of a multiplex PCR assay for rapid detection of toxigenic Vibrio cholerae O1 and O139. FEMS Immunol Med Microbiol (1998) 2.98
Structural changes are associated with soluble N-ethylmaleimide-sensitive fusion protein attachment protein receptor complex formation. J Biol Chem (1997) 2.96
CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J Neurosci (1996) 2.93
Vam3p structure reveals conserved and divergent properties of syntaxins. Nat Struct Biol (2001) 2.92
Synaptotagmin I is a high affinity receptor for clathrin AP-2: implications for membrane recycling. Cell (1994) 2.92
Binding properties of neuroligin 1 and neurexin 1beta reveal function as heterophilic cell adhesion molecules. J Biol Chem (1997) 2.88
Dynamin GTPase regulated by protein kinase C phosphorylation in nerve terminals. Nature (1993) 2.84